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STATE-OF-THE-ART PAPERS STATE-OF-THE-ART PAPERS1455Endothelial Dysfunction, Arterial Stiffness, and HFCatherine N. Marti, Mihai Gheorghiade, Andreas P. Kalogeropoulos, Vasiliki V. Georgiopoulou,
Arshed A. Quyyumi, Javed Butler
Several recent clinical trials for heart failure (HF) with preserved ejection fraction have been
negative or neutral. Marti and colleagues propose that a better understanding of the
pathophysiology of HF is needed, particularly regarding the role of vascular function.
Endothelial function and nitric oxide availability affect myocardial function, systemic and
pulmonary hemodynamics, and coronary and renal circulation. Arterial stiffness modulates
ventricular loading conditions and diastolic function. Endothelial function and arterial
stiffness, therefore, may serve as important physiologic targets for new HF therapies and
identify patients more likely to benefit from a proposed intervention.STATE-OF-THE-ART PAPERS1470Newer Imaging Techniques for Quantifying Mitral RegurgitationPaaladinesh Thavendiranathan, Dermot Phelan, James D. Thomas, Scott D. Flamm, Thomas H. Marwick
Accurate assessment of mitral regurgitation (MR) severity is important for prognostication
and decisions regarding surgical intervention. The most common method for noninvasive
assessment of MR has been with 2-dimensional transthoracic echocardiography, which is
often used as a qualitative tool. Thavendiranathan and colleagues review several newer
noninvasive modalities including 3-dimensional echocardiography, cardiac magnetic resonance
imaging, and cardiac computed tomography for quantifying MR severity.(continued on page A-20)
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FSPECIAL ARTICLE1484The NCDR Data Quality ProgramJohn C. Messenger, Kalon K.L. Ho, Christopher H. Young, Lara E. Slattery, Jasmine C. Draoui,
Jeptha P. Curtis, Gregory J. Dehmer, Frederick L. Grover, Michael J. Mirro, Matthew R. Reynolds,
Ivan Rokos, John A. Spertus, Tracy Y. Wang, Stuart A. Winston, John S. Rumsfeld, Frederick A. Masoudi,
on behalf of the National Cardiovascular Data Registry Science and Quality Oversight Committee Data
Quality Workgroup
Since its inception in 1997, the National Cardiovascular Data Registry (NCDR) has been the
basis for the development of performance and quality metrics, site-level quality improvement
programs, and peer-reviewed health outcomes research. The Data Quality Program (DQP) of
the NCDR is tasked with ensuring the completeness, consistency, and accuracy of data
submitted to the observational clinical registries. In this paper, Messenger and colleagues
describe the activities of the DQP and report the participant average raw accuracy of data
abstraction for the 3 main registries of the NCDR. They conclude that the 2,010 audits show
that the NCDR accurately represent the data from the medical charts.CLINICAL RESEARCH CARDIOVASCULAR RISK1489Measurements of C-IMT and of ICCAD Improve Prediction of CVEsDamiano Baldassarre, Anders Hamsten, Fabrizio Veglia, Ulf de Faire, Steve E. Humphries, Andries J. Smit,
Philippe Giral, Sudhir Kurl, Rainer Rauramaa, Elmo Mannarino, Enzo Grossi, Rodolfo Paoletti,
Elena Tremoli, on behalf of the IMPROVE Study Group
Baldassarre and colleagues compared the performance of several measures of carotid intima-
media thickness (C-IMT) alone, or in combination, as predictors of cardiovascular events
(CVEs). Almost 4,000 subjects were followed for 3 years. The average of 8 maximal IMT
measurements (IMTmean-max), alone or combined with, the inter-adventitia common carotid
rtery diameter (ICCAD), classified events and nonevents better than the common carotid
ean IMT. Adjusted Kaplan-Meier curves showed that an individual with an average
ramingham Risk Score, and both IMTmean-max and ICCAD above the median, had a 6.5%
risk to develop a CVE over 3 years compared to a 3.4% risk for those with the same FRS,
and both IMTmean-max and ICCAD below the median.
Editorial Comment: Michiel L. Bots, Hester M. den Ruijter, p. 1500(continued on page A-22)
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aCARDIOVASCULAR RISK1503PPA Predicts Mortality Risk in Frail Elderly PatientsAthanase Benetos, Sylvie Gautier, Carlos Labat, Paolo Salvi, Filippo Valbusa, Francesca Marino,
Olivier Toulza, Davide Agnoletti, Mauro Zamboni, Delphine Dubail, Patrick Manckoundia, Yves Rolland,
Olivier Hanon, Christine Perret-Guillaume, Patrick Lacolley, Michel E. Safar, Francis Guillemin
The longitudinal PARTAGE study sought to determine the predictive value of blood
pressure (BP) and pulse pressure amplification (PPA) measurements for predicting overall
mortality and major cardiovascular (CV) events in subjects over 80 years of age living in
nursing homes. During the 2-year follow-up, a 10% increase in PPA was associated with a
24% decrease in total mortality and a 17% decrease in major CV events. Systolic BP, diastolic
BP, and PP were either not associated or inversely correlated with total mortality and major
CV events.CARDIOVASCULAR RISK1512Subset of Monocytes Linked to Worse Cardiac OutcomesKyrill S. Rogacev, Bodo Cremers, Adam M. Zawada, Sarah Seiler, Nadine Binder, Philipp Ege,
Gunnar Große-Dunker, Isabel Heisel, Florian Hornof, Jana Jeken, Niko M. Rebling, Christof Ulrich,
Bruno Scheller, Michael Böhm, Danilo Fliser, Gunnar H. Heine
Rogacev and colleagues prospectively analyzed cardiovascular events in 951 subjects referred
for elective coronary angiography. Patients were categorized according to quartiles of total
monocyte and monocyte subset counts. In an univariate analysis, counts of total, classical
(CD14CD16), and intermediate (CD14CD16 ) monocytes predicted the
rimary endpoint, while nonclassical monocytes did not. After full adjustment for
onfounders, CD14CD16 monocytes remained independently related to cardiovascular
vents (4th vs. 1st quartile: hazard ratio: 3.0). Future studies are needed to elucidate whether
D14CD16 monocytes should be targeted for new therapeutic strategies in
therosclerosis.(continued on page A-24)
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1521Supervised ET Program Results in
Long-Term Improvements in QOL and Cardiac FunctionRomualdo Belardinelli, Demetrios Georgiou, Giovanni Cianci, Augusto Purcaro
Belardinelli and colleagues studied whether a long-term (10-year) supervised exercise training
(ET) program would produce sustained improvements in functional capacity and quality of
life (QOL) in chronic heart failure patients with systolic dysfunction. Subjects with ejection
fraction (EF) 40% were randomized to ET at 60% of peak VO2, 2 times a week or a
nontrained group. In ET patients, peak VO2 was above predicted VO2max each year during
the 10-year study, whereas it progressively decreased in the control population. QOL scores
were significantly higher with ET, and ET patients also had lower rates of hospital
readmission and cardiac mortality. This study shows remarkable and durable efficacy of ET
for patients with systolic heart failure.Editorial Comment: David J. Whellan, p. 1529HEART FAILURE
1531Radiofrequency Ablation of Premature Ventricular Ectopy Improves
the Efficacy of CRT in NonrespondersDhanunjaya Lakkireddy, Luigi Di Biase, Kay Ryschon, Mazda Biria, Vijay Swarup, Yeruva Madhu Reddy,
Atul Verma, Sudharani Bommana, David Burkhardt, Raghuveer Dendi, Antonio Dello Russo,
Michela Casella, Corrado Carbucicchio, Claudio Tondo, Buddhadeb Dawn, Andrea Natale
Lakkireddy and colleagues examined whether suppressing premature ventricular contractions
(PVCs) using radiofrequency ablation would improve the effectiveness of cardiac
resynchronization therapy (CRT) in nonresponders. A total of 65 CRT nonresponders
with 10,000 PVCs in 24 h underwent PVC ablation. There were significant improvements
in left ventricular (LV) ejection fraction and LV end-systolic volume. PVC ablation may
enhance CRT efficacy in nonresponders with significant PVC burden, although a randomized
trial is needed.(continued on page A-25)
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1540Trends in Permanent PM Implantation in the United States:
Increasing Complexity of Patients and ProceduresArnold J. Greenspon, Jasmine D. Patel, Edmund Lau, Jorge A. Ochoa, Daniel R. Frisch, Reginald T. Ho,
Behzad B. Pavri, Steven M. Kurtz
Greenspon and colleagues analyzed a large national database to identify contemporary trends
in pacemaker (PM) utilization in the United States. The Nationwide Inpatient Sample (NIS)
was queried to identify PM implants between 1993 and 2009. During this time, overall
utilization increased by 56%, with 47 implantations/100,000 persons in 1993 increasing to
62 implantations/100,000 persons in 2009. Patient age and Charlson Co-morbidity Index
increased over time as did hospital charges. This study shows steady growth in the utilization
of PMs in the United States with patients getting older and sicker.CARDIAC IMAGING
1546Comparison Between Cardiovascular Magnetic Resonance and Positron
Emission Tomography for Quantification of Absolute Myocardial PerfusionGeraint Morton, Amedeo Chiribiri, Masaki Ishida, Shazia T. Hussain, Andreas Schuster,
Andreas Indermuehle, Divaka Perera, Juhani Knuuti, Stacey Baker, Erik Hedström, Paul Schleyer,
Michael O’Doherty, Sally Barrington, Eike Nagel
Absolute quantification of myocardial perfusion and myocardial perfusion reserve (MPR)
using PET have proven diagnostic and prognostic roles in patients with CAD. Quantitative
cardiovascular magnetic resonance (CMR) perfusion imaging has been established more
recently, but has not been validated against PET in patients with CAD. A total of 41
patients with known or suspected CAD underwent quantitative 13N-ammonia PET and
CMR perfusion imaging prior to coronary angiography. There was high correlation between
CMR-derived MPR and PET-derived measurements, though absolute measurements
correlated only weakly. Area under the receiver-operating characteristic curves for detecting
CAD were similar for both techniques. These results confirm the value of CMR perfusion
imaging, but further refinements are needed before the techniques can be used
interchangeably for measuring absolute perfusion.
Editorial Comment: Bernhard L. Gerber, p. 1556(continued on page A-26)
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dHYPERTENSION1558Human Hypertension Is Characterized by a Lack of Activation of ANP and BNPFima Macheret, Denise Heublein, Lisa C. Costello-Boerrigter, Guido Boerrigter, Paul McKie, Diego Bellavia,
Sarah Mangiafico, Yasuhiro Ikeda, Kent Bailey, Christopher G. Scott, Sharon Sandberg, Horng H. Chen,
Valentina Cannone, Lorenzo Malatino, Margaret M. Redfield, Richard Rodeheffer, John Burnett, Jr,
Alessandro Cataliotti
Macheret and colleagues studied plasma levels of circulating atrial natriuretic peptide (ANP)
and B-type natriuretic peptide (BNP) and their potential contribution to human
hypertension. Compared to normotensive subjects, BNP1-32 and NT-proBNP1-76 were
ignificantly decreased in those with pre-hypertension, and BNP1-32 was significantly
ecreased in stage 1 hypertension as well. NT-ANP1-98 was also lower in subjects with pre-
hypertension. These results suggest impaired production and/or release of proBNP1-108 along
with a concomitant reduction of BNP1-32 and NT-proBNP1-76 in the early stages of
hypertension.GENETICS AND GENOMICS
1566R222Q SCN5A Mutation Is Associated With
Reversible Ventricular Ectopy and DCMStefan A. Mann, Maria L. Castro, Monique Ohanian, Guanglan Guo, Poonam Zodgekar, Angela Sheu,
Kathryn Stockhammer, Tina Thompson, David Playford, Rajesh Subbiah, Dennis Kuchar, Anu Aggarwal,
Jamie I. Vandenberg, Diane Fatkin
Mann and colleagues studied a variant in the SCN5A gene, which encodes the alpha-subunit
of the cardiac sodium channel, that was identified in 1 large kindred with dilated
cardiomyopathy (DCM) and multiple arrhythmias. Patch-clamp studies showed that the
variant, R222Q, produced current responses of earlier onset and greater magnitude than
wild-type channels. Action potential modeling suggested that rate-dependent ectopy of
Purkinje fiber origin is the predominant ventricular effect of the R222Q variant. In R222Q
carriers, premature ventricular contractions and DCM were substantially reduced by sodium
channel-blocking drugs. The R222Q SCN5A variant has an activating effect on sodium
channel function and is associated with reversible ventricular ectopy and DCM.
